We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more
Ask ADVFN Intelligence (AI)
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...
– Tourmaline assembles leading experts to support the development of pacibekitug for cardiovascular diseases – – Cardiovascular Scientific Advisory Board expected to provide strategic guidance as...
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.74 | 10.736677116 | 25.52 | 29.18 | 23.9 | 363624 | 26.60239768 | CS |
| 4 | 5.73 | 25.4327563249 | 22.53 | 29.18 | 21.69 | 338305 | 25.63659513 | CS |
| 12 | 10.86 | 62.4137931034 | 17.4 | 29.18 | 13.03 | 207310 | 21.83069139 | CS |
| 26 | 11.7 | 70.652173913 | 16.56 | 29.18 | 12.12 | 263742 | 17.3829455 | CS |
| 52 | 17.94 | 173.837209302 | 10.32 | 48.31 | 9.18 | 260983 | 22.87363197 | CS |
| 156 | 17.94 | 173.837209302 | 10.32 | 48.31 | 9.18 | 260983 | 22.87363197 | CS |
| 260 | 17.94 | 173.837209302 | 10.32 | 48.31 | 9.18 | 260983 | 22.87363197 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
